Conditions: Diabetes Diabetes Mellitus, Type 1
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 178
Healthy volunteers: no

Brief summary:
This trial is conducted in Europe, Oceania and the United States of America (USA). The aim of this trial is to compare two NN1250 (insulin degludec) formulations with each other and with insulin glargine, all in combination with insulin aspart in subjects with type 1 diabetes.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: insulin degludec intervention 2: insulin degludec intervention 3: insulin glargine intervention 4: insulin aspart
Intervention descriptions: intervention 1: Formulation 1: Treat-to-target dose titration scheme, injection s.c. (under the skin), once daily intervention 2: Formulation 2: Treat-to-target dose titration scheme, injection s.c. (under the skin), once daily intervention 3: Treat-to-target dose titration scheme, injection s.c., once daily intervention 4: Treat-to-target dose titration scheme, injection s.c. (under the skin), 3 times daily

Protocol document: